Delivery Order SPE2DR25D3017-SPE2DR26F3FL4
- Not listed
- The Defense Logistics Agency awarded a $1,086.00 delivery order to AmerisourceBergen Drug Corp for Ezetimibe 10 mg tablets (20-count unit dose packaging) on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle valued through December 2026 that enables the company to supply...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $1,033.38 to Amerisourcebergen Drug Corporation for 500 tablets of Ezetimibe 10 mg. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 23 to August 24, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor to supply the generic cholesterol medication to the Defense Logistics...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ezetimibe 10 mg tablets. The $8,313.85 firm fixed-price contract has a performance period through May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,196.15 firm-fixed-price delivery order is for the supply of 4,565,243,581 units of the drug ezetimibe 10 mg tablets. There is no set-aside designation for this contract, which has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $218,690 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of 90 tablets of 10 mg Ezetimibe per package. The prime contractor, AmerisourceBergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania by the period of performance end date of August 21, 2023. The Defense Logistics Agency supports Department of Defense procurement programs through...
- The Defense Logistics Agency awarded a $2,733 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 500 bottles of Ezetimibe 10 mg tablets. The firm fixed price contract has a period of performance from July 14, 2023 through July 17, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $3,157.77 firm fixed price delivery order is for the supply of 500 units of the pharmaceutical drug Ezetimibe 10 mg tablets. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves as...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,142.40 for the supply of 4567794734 EZETIMIBE 10 MG TABLET 500S, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ezetimibe-Simvastatin 10-40 mg tablets in a quantity of 1,000 units. Valued at $1,091.55 with a firm fixed price structure, this non-set-aside contract is scheduled for completion by September 2, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,743 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of Ezetimibe 10 mg. To be performed at the prime contractor's facility in Conshohocken, Pennsylvania, the order calls for delivery between September 14-15, 2023. Ezetimibe is a cholesterol-lowering medication commonly used to treat high cholesterol as part of the DLA's medical supply chain supporting the U.S. Department of...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3FL4Delivery Order
The Defense Logistics Agency has awarded a delivery order valued at $1,442.95 to AmerisourceBergen Drug Corp for 500 tablets of Ezetimibe 10 mg, with a completion date of January 12, 2026. This is a firm fixed-price, non-set-aside contract awarded on January 9, 2026, with performance to be executed in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor serving defense and military healthcare systems. The company's contract portfolio with the Defense Logistics Agency encompasses diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order for Ezetimibe, a cholesterol-management medication, exemplifies the routine pharmaceutical procurement through the DLA Medical Supply Chain that supports troops and military treatment facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/8/26 |